Poximune AE

Company: Ceva Biomune

Avian Encephalomyelitis-Fowl Pox Vaccine, Live Virus

U.S. Vet. Lic. No.: 368

Contents: POXIMUNE^® AE contains live fowl pox virus vaccine and live avian encephalomyelitis virus vaccine for the vaccination of chickens as an aid in the prevention of fowl pox and avian encephalomyelitis.

Contains gentamicin and amphotericin B as preservatives.

Poximune AE Indications

Administer by wing web to healthy, susceptible chickens at least eight weeks of age but at least four weeks prior to the start of egg production as an aid in the prevention of fowl pox due to fowl pox virus and avian encephalomyelitis due to avian encephalomyelitis virus.

Dosage and Administration

Remove seal and stopper from vaccine vial and diluent vial. Pour entire contents of diluent vial into vaccine vial, insert stopper, and shake well. The vaccine is ready for use and should be used within one hour. Hold each individual bird and spread the wing with the underside facing up. Dip the applicator into the vaccine so that the grooves fill with liquid and deliver 0.01 mL per bird. Insert the double-pronged applicator into the web portion of the wing avoiding blood vessels, muscle, and bone. Seven to ten days after vaccination, observe several chickens for evidence of “takes” that include swelling and/or scab formation at the site of injection.

Precaution(s): Federal regulations prohibit repackaging or sale of the contents of this package in fractional units. Do not accept if seal is broken.

Store vaccine at 35-45°F (2-7°C).

Use entire contents immediately after rehydrating. Burn containers and all unused contents.

Caution(s): All birds on a farm should be vaccinated at one time.

Warning(s): Do not vaccinate within 21 days of slaughter.

678

Presentation: 10 x 1,000 doses.

CPN: 11290411